Physician profile
Brian Robert Reece
NPI 1568089084
$2,008.04
in general payments reported to CMS, 2019-2025
17 companies · $679 in 2025
The $679 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $194 · 2022: $252 · 2023: $392 · 2024: $491 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,467 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,466.58 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $527.87 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $221.99 | 2022-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $218.97 | 2022-2025 | |
| Amgen INC. | $158.93 | 2023-2025 | Otezla, Otezla |
| Leo Pharma INC. | $137.98 | 2024-2025 | Adbry, Anzupgo |
| Janssen Biotech, INC. | $134.55 | 2023-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $106.04 | 2021-2025 | Ilumya |
| Lilly USA, LLC | $97.70 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Genzyme Corporation | $87.99 | 2024-2025 | |
| Pfizer INC. | $73.38 | 2023-2025 | |
| Ucb, INC. | $68.45 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $60.24 | 2022-2025 | Nemluvio |
| Regeneron Healthcare Solutions, INC. | $58.05 | 2024-2025 | Dupixent |
| Krystal Biotech INC | $20.15 | 2025 | Vyjuvek |
| Mallinckrodt Hospital Products INC. | $19.50 | 2025 | Acthar |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.62 | 2023 | Grafix |
| Biofrontera INC. | $1.63 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.